Regulation of levels of guanosine cyclic 3',5'-monophosphate in the central nervous system: effects of depolarizing agents.
D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D002490:Central Nervous System / Q000187:drug effects / Q000378:metabolism*; D002531:Cerebellum / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000032:analysis / Q000378:metabolism*; D004347:Drug Interactions; D005260:Female; D051379:Mice; D008815:Mice, Inbred Strains; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors; D014702:Veratrine / Q000494:pharmacology
D009467:Neuromuscular Depolarizing Agents; D010042:Ouabain; D013806:Theophylline; D000242:Cyclic AMP; D014702:Veratrine; D006152:Cyclic GMP; D000241:Adenosine; D011188:Potassium